89Bio Inc (ETNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,681 | -142,189 | -101,954 | -67,229 | -28,836 |
| Depreciation Amortization | 171 | -5,318 | -3,568 | -1,708 | 233 |
| Accounts payable and accrued liabilities | 6,767 | -3,917 | -1,599 | -1,787 | 4,225 |
| Other Working Capital | 9,439 | 657 | -2,773 | -4,574 | -5,242 |
| Other Operating Activity | -4,416 | 21,581 | 15,001 | 10,766 | -465 |
| Operating Cash Flow | $-39,720 | $-129,186 | $-94,893 | $-64,532 | $-30,085 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -4 | N/A | N/A | N/A |
| Purchase Of Investment | -79,898 | -123,015 | -59,376 | -97,702 | 4,106 |
| Investing Cash Flow | $-79,898 | $-123,019 | $-59,376 | $-97,702 | $4,106 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 24,363 | 24,363 | 24,363 | 24,363 |
| Debt Repayment | N/A | -21,400 | -21,400 | -21,400 | -21,400 |
| Common Stock Issued | 21,171 | 512,423 | 350,267 | 350,150 | 310,424 |
| Other Financing Activity | -141 | -2,275 | -2,290 | -693 | 8,267 |
| Financing Cash Flow | $21,030 | $513,111 | $350,940 | $352,420 | $321,654 |
| Beginning Cash Position | 316,161 | 55,255 | 55,255 | 55,255 | 55,255 |
| End Cash Position | 217,573 | 316,161 | 251,926 | 245,441 | 350,930 |
| Net Cash Flow | $-98,588 | $260,906 | $196,671 | $190,186 | $295,675 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,720 | -129,186 | -94,893 | -64,532 | -30,085 |
| Capital Expenditure | N/A | -4 | N/A | N/A | N/A |
| Free Cash Flow | -39,720 | -129,190 | -94,893 | -64,532 | -30,085 |